Compare BLE & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLE | POM |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Other Specialty Stores |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 496.0M | 555.4M |
| IPO Year | N/A | 2025 |
| Metric | BLE | POM |
|---|---|---|
| Price | $10.39 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 108.3K | ★ 5.6M |
| Earning Date | 01-01-0001 | 12-03-2025 |
| Dividend Yield | ★ 4.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | N/A | ★ $51,210,721.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1,082.00 | ★ N/A |
| Revenue Growth | N/A | ★ 12.13 |
| 52 Week Low | $8.77 | $0.26 |
| 52 Week High | $10.95 | $6.43 |
| Indicator | BLE | POM |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | N/A |
| Support Level | $10.35 | N/A |
| Resistance Level | $10.47 | N/A |
| Average True Range (ATR) | 0.07 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 50.03 | 0.00 |
Blackrock Municipal Income Trust II is a perpetual closed-end municipal bond fund. Its objective is to provide a high current income exempt from federal income taxes. The fund invests a majority of its managed assets in municipal obligations issued by or on behalf of states, territories, and possessions of the United States and their political subdivisions, agencies, or instrumentalities (Municipal Bonds), the interest of which is exempt from regular federal income tax (except that the interest may be subject to the alternative minimum tax).
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.